← Back to Clinical Trials
Recruiting NCT05768802

NCT05768802 Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05768802
Status Recruiting
Phase
Sponsor Boninger, Michael, MD
Condition Amputation
Study Type INTERVENTIONAL
Enrollment 5 participants
Start Date 2026-01-16
Primary Completion 2029-12

Trial Parameters

Condition Amputation
Sponsor Boninger, Michael, MD
Study Type INTERVENTIONAL
Phase N/A
Enrollment 5
Sex ALL
Min Age 22 Years
Max Age 70 Years
Start Date 2026-01-16
Completion 2029-12
Interventions
Myoelectric Implantable Recording Array (MIRA)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research study is to see how well a new type of myoelectric prosthesis works. A myoelectric prosthesis is a robotic limb for amputees that is controlled by sensing the activity of muscles in the body above the amputation level. This study involves a medical procedure to implant the Myoelectric Implantable Recording Array (MIRA) in the residual limb. The procedure will be performed under sedation by a physician. When muscles contract, they generate an electrical signal that can be sensed by MIRA and used to control the prosthetic limb. Myoelectric prosthetic limbs normally use electrodes that are placed on the surface of the skin to control different movements. However, MIRA is implanted under the skin, which could improve the ability to control the myoelectric prosthesis. After the MIRA is implanted, training will occur to learn how to control the prosthesis using the muscles in the residual limb. The device can stay implanted for up to one year. The device will be removed (explanted) by a physician.

Eligibility Criteria

Inclusion Criteria: 1. Subjects must have a unilateral transradial amputation or wrist disarticulation. 2. Subjects must demonstrate independent voluntary control of muscles in the flexor and extensor compartments of the forearm 3. Subjects must be over 1-year post-amputation at time of implantation. 4. Subjects must be between the ages of 22 and 70 years old. Subjects outside this age range may be at an increased surgical risk and increased risk of fatigue during prosthetic training. 5. Subjects must be able to communicate with the investigators in English because of the need to follow the instructions of the study team. 6. Subjects must show an understanding of the study goals and have the ability to follow simple directions as judged by the investigators. 7. Subjects must pass a neuropsychological and psychosocial assessment. 8. Documentation of informed consent must be obtained from the subject. Exclusion Criteria: 1. Subjects must be able to function without the use of a prosthesi

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology